Duchenne muscular dystrophy (DMD) is characterized by progressive muscle degeneration. Two important deleterious features are a Ca2+ dysregulation...
Array
(
[id_prestablog_news] => 1528
[id_shop] => 1
[date] => 2022-03-17 00:00:00
[date_modification] => 2024-02-09 14:15:13
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 3260
[id_lang] => 2
[title] => CD38_NADase is a new major contributor to Duchenne muscular dystrophic phenotype
[paragraph] => CD38_NADase is a new major contributor to Duchenne muscular dystrophic phenotype
[content] => Authors
A de Zelicourt, A Fayssoil, M Dakouane_Giudicelli et al
Lab
Universite Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France.
Journal
EMBO Molecular Medicine
Abstract
Duchenne muscular dystrophy (DMD) is characterized by progressive muscle degeneration. Two important deleterious features are a Ca2+ dysregulation linked to Ca2+ influxes associated with ryanodine receptor hyperactivation, and a muscular nicotinamide adenine dinucleotide (NAD+ ) deficit. Here, we identified that deletion in mdx mice of CD38, a NAD+ glycohydrolase-producing modulators of Ca2+ signaling, led to a fully restored heart function and structure, with skeletal muscle performance improvements, associated with a reduction in inflammation and senescence markers. Muscle NAD+ levels were also fully restored, while the levels of the two main products of CD38, nicotinamide and ADP-ribose, were reduced, in heart, diaphragm, and limb. In cardiomyocytes from mdx/CD38-/- mice, the pathological spontaneous Ca2+ activity was reduced, as well as in myotubes from DMD patients treated with isatuximab (SARCLISA ) a monoclonal anti-CD38 antibody. Finally, treatment of mdx and utrophin-dystrophin-deficient (mdx/utr-/- ) mice with CD38 inhibitors resulted in improved skeletal muscle performances. Thus, we demonstrate that CD38 actively contributes to DMD physiopathology. We propose that a selective anti-CD38 therapeutic intervention could be highly relevant to develop for DMD patients.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
[meta_description] =>
[meta_keywords] => https://doi.org/10.15252/emmm.202012860
[meta_title] =>
[link_rewrite] => cd38nadase-is-a-new-major-contributor-to-duchenne-muscular-dystrophic-phenotype
[actif_langue] => 1
[read] => 985
[count_comments] => 0
[id] => 1528
[categories] => Array
(
[44] => Array
(
[id_prestablog_categorie] => 44
[title] => Myopathie de Duchenne
[link_rewrite] => Myopathie-de-Duchenne
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => CD38_NADase is a new major contributor to Duchenne muscular dystrophic phenotype
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Test d'agrippement
[description_short] => Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.
Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html
)
)
)
1 En lire plus